News Novo's next-gen diabetes drug could be best at cutting heart... Novo boosted by results from next-gen GLP-1.
News NHS to fund Pfizer's Bosulif and Lilly's Alimta NICE is reviewing drugs from old Cancer Drugs Fund.
News Bad news for Sanofi as biosimilar replaces Lantus Pharmacy benefit firm axes Lantus, decision due on key combination therapy.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
